Finding 1236752 (2023-012)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
-
Year
2023
Accepted
2026-09-25
Audit: 412274
Auditor: CBIZ CPAS PC

Finding Text

No text available

Categories

No categories assigned yet.

Other Findings in this Audit

  • 1236723 2023-009
    Material Weakness Repeat
  • 1236724 2023-009
    Material Weakness Repeat
  • 1236725 2023-009
    Material Weakness Repeat
  • 1236726 2023-009
    Material Weakness Repeat
  • 1236727 2023-009
    Material Weakness Repeat
  • 1236728 2023-009
    Material Weakness Repeat
  • 1236729 2023-009
    Material Weakness Repeat
  • 1236730 2023-009
    Material Weakness Repeat
  • 1236731 2023-009
    Material Weakness Repeat
  • 1236732 2023-009
    Material Weakness Repeat
  • 1236733 2023-010
    Material Weakness Repeat
  • 1236734 2023-010
    Material Weakness Repeat
  • 1236735 2023-010
    Material Weakness Repeat
  • 1236736 2023-010
    Material Weakness Repeat
  • 1236737 2023-010
    Material Weakness Repeat
  • 1236738 2023-010
    Material Weakness Repeat
  • 1236739 2023-010
    Material Weakness Repeat
  • 1236740 2023-010
    Material Weakness Repeat
  • 1236741 2023-010
    Material Weakness Repeat
  • 1236742 2023-011
    Material Weakness Repeat
  • 1236743 2023-011
    Material Weakness Repeat
  • 1236744 2023-011
    Material Weakness Repeat
  • 1236745 2023-011
    Material Weakness Repeat
  • 1236746 2023-011
    Material Weakness Repeat
  • 1236747 2023-011
    Material Weakness Repeat
  • 1236748 2023-011
    Material Weakness Repeat
  • 1236749 2023-011
    Material Weakness Repeat
  • 1236750 2023-011
    Material Weakness Repeat
  • 1236751 2023-012
    Material Weakness Repeat
  • 1236753 2023-012
    Material Weakness Repeat
  • 1236754 2023-012
    Material Weakness Repeat
  • 1236755 2023-012
    Material Weakness Repeat
  • 1236756 2023-012
    Material Weakness Repeat
  • 1236757 2023-012
    Material Weakness Repeat
  • 1236758 2023-012
    Material Weakness Repeat
  • 1236759 2023-012
    Material Weakness Repeat
  • 1236760 2023-013
    Material Weakness Repeat
  • 1236761 2023-013
    Material Weakness Repeat
  • 1236762 2023-013
    Material Weakness Repeat
  • 1236763 2023-013
    Material Weakness Repeat
  • 1236764 2023-013
    Material Weakness Repeat
  • 1236765 2023-013
    Material Weakness Repeat
  • 1236766 2023-013
    Material Weakness Repeat
  • 1236767 2023-013
    Material Weakness Repeat
  • 1236768 2023-013
    Material Weakness Repeat
  • 1236769 2023-013
    Material Weakness Repeat
  • 1236770 2023-014
    Material Weakness Repeat
  • 1236771 2023-014
    Material Weakness Repeat
  • 1236772 2023-014
    Material Weakness Repeat
  • 1236773 2023-014
    Material Weakness Repeat
  • 1236774 2023-014
    Material Weakness Repeat
  • 1236775 2023-014
    Material Weakness Repeat
  • 1236776 2023-014
    Material Weakness Repeat
  • 1236777 2023-014
    Material Weakness Repeat
  • 1236778 2023-014
    Material Weakness Repeat
  • 1236779 2023-014
    Material Weakness Repeat
  • 1236780 2023-015
    Material Weakness Repeat
  • 1236781 2023-016
    Material Weakness Repeat
  • 1236782 2023-016
    Material Weakness Repeat
  • 1236783 2023-016
    Material Weakness Repeat
  • 1236784 2023-016
    Material Weakness Repeat
  • 1236785 2023-016
    Material Weakness Repeat
  • 1236786 2023-016
    Material Weakness Repeat
  • 1236787 2023-016
    Material Weakness Repeat
  • 1236788 2023-016
    Material Weakness Repeat
  • 1236789 2023-016
    Material Weakness Repeat
  • 1236790 2023-016
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.914 HIV EMERGENCY RELIEF PROJECT GRANTS $827,117
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $547,532
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $400,743
93.788 OPIOID STR $275,534
93.136 INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS $257,074
93.917 HIV CARE FORMULA GRANTS $58,312
93.242 MENTAL HEALTH RESEARCH GRANTS $41,967
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $25,429
93.940 HIV PREVENTION AND SURVEILLANCE ACTIVITIES-HEALTH DEPARTMENT BASED $4,314